ASX:LGP Little Green Pharma (LGP) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free LGP Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Little Green Pharma alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Little Green PharmaLittle Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. It offers dried cannabis flower medicines, cannabis oils, tinctures, capsules, and APIs. The company was incorporated in 2016 and is based in West Perth, Australia.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> LGP Stock News HeadlinesNovember 14, 2023 | proactiveinvestors.com.auLittle Green Pharma focused on European expansionNovember 13, 2023 | ca.finance.yahoo.comLittle Green Pharma Ltd (LGP.XA)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 9, 2023 | finance.yahoo.comLittle Green Pharma Slides As Insider Purchases Lose Another AU$58kSeptember 7, 2023 | msn.comWeed Week: Growing excitement for cannabis stocks after marijuana rescheduling hopes in the USAugust 16, 2023 | msn.comASX Health Stocks: Lumos surges 25pc after patent grant in Europe and JapanJuly 9, 2023 | afr.comAussie cannabis player Little Green Pharma pins growth hopes on EuropeJune 2, 2023 | finance.yahoo.comLittle Green Pharma Full Year 2023 Earnings: AU$0.034 loss per share (vs AU$0.10 loss in FY 2022)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.June 1, 2023 | lse.co.ukSeed Innovations investee company Little Green Pharma sees growthMay 15, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of Little Green Pharma Ltd (ASX:LGP)May 4, 2023 | au.finance.yahoo.comLittle Green Pharma Ltd (LGP.AX)April 1, 2023 | finance.yahoo.comInsider Buying: Alexander Waislitz Just Spent AU$100k On Little Green Pharma Ltd (ASX:LGP) SharesMarch 24, 2023 | msn.comLittle Green Pharma share price shoots 13% higher after capital raiseMarch 22, 2023 | msn.comASX Health Stocks: TGA’s new ruling has cannabis stocks rushing toward psychedelics – LGP is one of themMarch 21, 2023 | investing.comLittle Green Pharma Ltd (LGP)March 6, 2023 | proactiveinvestors.comMindset Pharma and PharmAla complete first sale of pharmaceutical-grade psilocybin into growing Australian market via sales partnershipFebruary 25, 2023 | wsj.comLittle Green Pharma Ltd.February 17, 2023 | lse.co.ukSeed Innovations highlights ethics approval at Little Green PharmaSee More Headlines Receive LGP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Little Green Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:LGP CUSIPN/A CIKN/A Webwww.littlegreenpharma.com Phone61 8 6280 0050FaxN/AEmployees120Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,140,000.00 Net Margins-15.29% Pretax MarginN/A Return on Equity-10.85% Return on Assets-4.61% Debt Debt-to-Equity Ratio7.15 Current Ratio3.24 Quick Ratio1.60 Sales & Book Value Annual Sales$23.24 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.27 per share Price / BookN/AMiscellaneous Outstanding Shares300,090,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.24 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Angus McDougall CaithnessCFO & Executive DirectorMs. Fleta Jennifer SolomonExecutive DirectorMr. Paul LongChief Executive OfficerMr. Alistair Warren B.A.L.L.B., General Counsel & Company SecretaryMs. Celia YoungHead of MarketingDr. Leon WarneHead of Research & InnovationMs. Gabriela FranzHead of Commercial Operations EuropeMs. Melanie PuglieseHead of EngagmentBrian WestergaardHead of ITMs. Barb FullertonHead of Sales & Distribution AUMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersAngus CaithnessSold 32,000 sharesTotal: $4,480.00 ($0.14/share)Neale FongBought 35,000 shares on 4/3/2024Total: $5,250.00 ($0.15/share)Beatriz BanzoSold 70,000 sharesTotal: $11,200.00 ($0.16/share)Neale FongSold 9,251 sharesTotal: $2,192.49 ($0.24/share) This page (ASX:LGP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Little Green Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
